Dronabinol is classed for a pregnancy Classification C drug, since it has not exhibited teratogenic outcomes in animal models at doses ranging from 0.2 to 5 periods the utmost recommended human dose. Even so, it is crucial to note that pregnant individuals haven't been subjected to adequatel